CINECA IRIS Institutional Research Information System

BROGLIO, Fabio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.698
EU - Europa 5.661
AS - Asia 3.062
SA - Sud America 306
OC - Oceania 157
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 5
Totale 16.930
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.429
CN - Cina 1.345
IT - Italia 809
DE - Germania 670
IE - Irlanda 662
UA - Ucraina 660
FR - Francia 542
SE - Svezia 535
GB - Regno Unito 412
FI - Finlandia 400
KR - Corea 389
SG - Singapore 386
PL - Polonia 219
BR - Brasile 204
CA - Canada 197
JP - Giappone 196
AT - Austria 192
AU - Australia 140
ES - Italia 135
VN - Vietnam 127
IN - India 99
TR - Turchia 94
NL - Olanda 89
RU - Federazione Russa 71
BE - Belgio 59
HK - Hong Kong 59
MX - Messico 57
ID - Indonesia 55
PH - Filippine 54
TW - Taiwan 45
IL - Israele 38
MY - Malesia 34
PT - Portogallo 32
AR - Argentina 31
CL - Cile 30
CH - Svizzera 28
GR - Grecia 27
DK - Danimarca 25
JO - Giordania 22
HU - Ungheria 21
IR - Iran 20
RO - Romania 19
NZ - Nuova Zelanda 17
TH - Thailandia 17
CO - Colombia 16
UZ - Uzbekistan 16
NO - Norvegia 14
PE - Perù 13
SN - Senegal 12
EG - Egitto 9
LB - Libano 9
QA - Qatar 8
RS - Serbia 8
SA - Arabia Saudita 7
SI - Slovenia 7
CZ - Repubblica Ceca 6
IQ - Iraq 6
PK - Pakistan 6
ZA - Sudafrica 6
CY - Cipro 5
EU - Europa 5
BG - Bulgaria 4
GE - Georgia 4
GT - Guatemala 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
AN - Antille olandesi 3
BD - Bangladesh 3
EC - Ecuador 3
EE - Estonia 3
KZ - Kazakistan 3
MK - Macedonia 3
SC - Seychelles 3
TN - Tunisia 3
UY - Uruguay 3
AZ - Azerbaigian 2
BH - Bahrain 2
HN - Honduras 2
IS - Islanda 2
LK - Sri Lanka 2
MU - Mauritius 2
MV - Maldive 2
NG - Nigeria 2
NP - Nepal 2
PR - Porto Rico 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
AL - Albania 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CU - Cuba 1
DZ - Algeria 1
ET - Etiopia 1
KW - Kuwait 1
LT - Lituania 1
LV - Lettonia 1
MA - Marocco 1
Totale 16.928
Salva come PNG Salva come JPEG
Città #
Beijing 1.005
Chandler 885
Dublin 646
Houston 451
Jacksonville 367
Villeurbanne 352
Fairfield 288
Singapore 284
Redwood City 246
Dearborn 228
Ann Arbor 221
Princeton 214
Medford 213
Ashburn 205
Wilmington 199
Nyköping 188
Vienna 180
Warsaw 175
Torino 144
Woodbridge 126
Milan 124
Boston 120
Seattle 113
Cambridge 107
Fremont 83
Boardman 71
Pisa 68
Dong Ket 67
Toronto 58
Verona 49
Turin 43
Santa Clara 40
Norwalk 38
Tokyo 37
Nanjing 33
São Paulo 33
Lachine 31
New York 31
Shanghai 31
Brussels 28
London 28
Mountain View 26
Taipei 26
Hefei 24
Washington 24
Falls Church 23
Ankara 22
Guangzhou 21
Munich 21
Santiago 21
Jakarta 20
Istanbul 19
Detroit 18
Sydney 18
Menlo Park 17
San Diego 17
San Mateo 17
Seoul 17
Cupertino 16
Duncan 16
Melbourne 16
Central District 15
Helsinki 15
Moscow 15
Berlin 14
Buenos Aires 14
Hangzhou 14
Jinan 14
Rome 14
Zhengzhou 14
Absecon 13
Amsterdam 13
Düsseldorf 13
Kuala Lumpur 13
Los Angeles 13
Birmingham 12
Central 12
Izmir 12
Kunming 12
Montreal 12
Redmond 12
Wuhan 12
Chicago 11
Ottawa 11
Philadelphia 11
Polska 11
Pune 11
Chengdu 10
Mexico 10
Nanchang 10
Padova 10
Alcalá De Henares 9
Brooklyn 9
Frankfurt am Main 9
Fuzhou 9
Hebei 9
Kiel 9
Madison 9
Mumbai 9
Trieste 9
Totale 8.703
Salva come PNG Salva come JPEG
Nome #
Is the timing of caloric intake associated with variation in diet-induced thermogenesis and in the metabolic pattern? A randomized cross-over study 2.420
Timing of food intake: sounding the alarm about metabolic impairments? A systematic review. 1.248
Effects of Self-Conditioning Techniques (Self-Hypnosis) in Promoting Weight Loss in Patients with Severe Obesity: A Randomized Controlled Trial 532
Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes 428
Effects of Self-Conditioning Techniques (Self-Hypnosis) in Promoting Weight Loss in Patients with Severe Obesity: A Randomized Controlled Trial 354
Impact of short-term treatment with benzodiazepines and imidazopyridines on glucose metabolism in healthy subjects. 281
Impaired taste sensation in type 2 diabetic patients without chronic complications: a case-control study 249
Ghrelin 210
Predictive role of the Mediterranean diet on mortality in individuals at low cardiovascular risk: A 12-year follow-up population-based cohort study 192
Changes in the gut microbiota composition during pregnancy in patients with gestational diabetes mellitus (GDM) 184
Acute effects of acylated ghrelin on salbutamol-induced metabolic actions in humans 175
The endocrine response to ghrelin as a function of gender in humans in young and elderly subjects. 160
Effects of meal timing on changes in circulating epinephrine, norepinephrine, and acylated ghrelin concentrations: A pilot study 150
The GH-releasing effect of acylated ghrelin in normal subjects is refractory to GH acute auto-feedback but is inhibited after short-term GH administration inducing IGF1 increase 150
Incidence of diabetes mellitus, cardiovascular outcomes and mortality after a 12-month lifestyle intervention: A 9-year follow-up 146
Changes in weight and nutritional habits in adults with obesity during the “lockdown” period caused by the COVID-19 virus emergency 120
Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes 11 Medical and Health Sciences 1103 Clinical Sciences 116
Activity of GH/IGF-I axis in patients with dilated cardiomyopathy 106
Ghrelin secretion is inhibited by glucose load and insulin-induced hypoglycaemia but unaffected by glucagon and arginine in humans 106
Dietary interventions modify the gut microbiota during pregnancy in patients with gestational diabetes mellitus (GDM) 103
Circulating ghrelin levels in newborns are not associated to gender, body weight and hormonal parameters but depend on the type of delivery. 101
Testing pituitary function in aging individuals 97
Cortistatin-8, a synthetic cortistatin-derived ghrelin receptor ligand, does not modify the endocrine responses to acylated ghrelin or hexarelin in humans 94
The nutritional status has no major role in the age-related reduction of IGF-I secretion. 94
HYPERCORTISOLISM DUE TO CUSHING’S DISEASE IS ASSOCIATED TO DERANGED GHRELIN SECRETION AND ACTION 93
Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. 92
Acute cardiovascular and hormonal effects of GH and hexarelin, a synthetic GH-releasing peptide, in humans 90
Endocrine and metabolic response to extreme altitude and physical exercise in athletes. 88
MEDIATORI CENTRALI E PERIFERICI DEL COMPORTAMENTO ALIMENTARE 88
The GH response to GHRH in normal adults is not affected by enalapril or furosemide while is blunted by digoxin. 87
Primary hyperparathyroidism is associated with an impaired secretion of growth hormone but not of the other anterior pituitary hormones. 86
Acetylcholine regulates ghrelin secretion in humans 85
ACTIVITY OF GH/IGF-I AXIS IN PATIENTS WITH DILATED CARDIOMYOPATHY 84
The continuous infusion of acylated ghrelin enhances growth hormone secretion and worsens glucose metabolism in humans 84
Sleep abnormalities in type 2 diabetes may be associated with glycemic control 83
The metabolic response to the activation ofthe beta-adrenergic receptor by salbutamol is amplified by acylated ghrelin 83
Cortistatin-17 and somatostatin-14 display the same effects on growth hormone, prolactin, and insulin secretion in patients with acromegaly or prolactinoma 82
Biologic activities of growth hormone secretagogues in humans. 81
Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH. 80
Activity of GH/IGF-I axis in burn patients: comparison with normal subjects and patients with growth hormone deficiency. 80
Ghrelin and synthetic growth hormone secretagogues are cardioactive molecules with identities and differences 80
Self-reported adherence to diet and preferences towards type of meal plan in patient with type 2 diabetes mellitus. A cross-sectional study. 79
Cardiac effects of hexarelin in hypopituitary adults. 78
d-Lys-GHRP-6 does not modify the endocrine response to acylated ghrelin or hexarelin in humans 78
CORTICOTROPH AND ADRENAL RESPONSIVENESS TO hCRH, HEXARELIN AND ACTH IN YOUNG AND ELDERLY SUBJECTS 77
Activity of GH/IGF-I axis in patients with dilated cardiomyopathy. 76
GHRELIN SECRETION IS INHIBITED BY GLUCOSE LOAD AND INSULIN-INDUCED HYPOGLYCEMIA BUT UNAFFECTED BY GLUCAGON AND ARGININE IN HUMANS 76
Acetylcholine does not play a major role in mediating the endocrine responses to ghrelin, a natural ligand of the GH secretagogue receptor, in humans. 76
Ghrelin inhibits LH pulsatile secretion in humans. 74
Ghrelin: endocrine, metabolic and cardiovascular actions 74
Ghrelin, hypothalamus-pituitary-adrenal (HPA) axis and Cushing's syndrome 73
Continuous glucose monitoring is more effective than mixed meal test in the diagnosis of post-gastric bypass reactive hypoglycemia 73
Age-related variations of the GH response to GH secretagogues in humans. 72
Acylated ghrelin inhibits spontaneous luteinizing hormone pulsatility and responsiveness to naloxone but not that to gonadotropin-releasing hormone in young men: evidence for a central inhibitory action of ghrelin on the gonadal axis 72
Endocrine and metabolic actions of ghrelin 72
Ghrelin: much more than a natural growth hormone secretagogue. 71
BASAL AND STIMULATED GH SECRETION IN CUSHING’S SYNDROME: EFFECTS OF GHRELIN AND GHRH+ARGININE 71
Activity of GH/IGF-I axis in patients with dilated cardiomyopathy 71
Circulating obestatin levels in normal and Type 2 diabetic subjects. 71
Brain-gut communication: cortistatin, somatostatin and ghrelin 70
Beta-adrenergic agonism does not impair the GH response to acylated ghrelin inhumans 69
Type 2 diabetes mellitus is associated with disruptions as a function of metabolic control. 69
Effect of desacyl ghrelin, obestatin and related peptides on triglyceride storage, metabolism and GHSR signaling in 3T3-L1 adipocytes 69
GH-independent cardiotropic activities of hexarelin in patients with severe left ventricular dysfunction due to dilated and ischemic cardiomyopathy. 68
Metabolic and endocrine effects of physiological increments in plasma ghrelin concentrations 68
Is HDL cholesterol protective in patients with type 2 diabetes? A retrospective population-based cohort study 68
EP1572: a novel peptido-mimetic GH secretagogue with potent and selective GH-releasing activity in man. 67
Effect of digoxin on the somatotroph responsiveness to growth hormone-releasing hormone (GHRH) alone or combined with arginine in normal young volunteers. 67
Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of Hexarelin and GHRP-2 in humans. 66
Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans 65
GH secretion is impaired in patients with primary hyperparathyroidism. 65
Cortistatin-17 and -14 exert the same endocrine activities as somatostatin in humans 65
Ghrelin and synthetic GH secretagogues. 65
Continuous glucose monitoring is more effective than mixed meal test in the diagnosis of post-gastric by pass reactive hypoglycemia 65
WRIST ACTIGRAPHY DOES NOT REVEAL SLEEP DISTURBANCES IN PATIENTS WITH ADDISON’S DISEASE UNDER CONVENTIONAL GLUCOCORTICOID REPLACEMENT THERAPY 65
Ghrelin: a new hormone with endocrine and non-endocrine activities 64
Cardiac effects of hexarelin in hypopituitary adults 63
H9c2 cardiac muscle cells express insulin-like growth factor binding protein-3 (IGFBP-3). 62
Activity of GH/IGF-I axis in trauma and septic patients during artificial nutrition: different behavior patterns? 62
Endocrine activities of alexamorelin (Ala-His-d-2-methyl-Trp-Ala-Trp-d-Phe-Lys-NH2), a synthetic GH secretagogue, in humans 62
Radionuclide angiocardiographic evaluation of the cardiovascular effects of recombinant human IGF-I in normal adults. 62
Other than Growth Hormone Neuroendocrine Actions of Ghrelin 62
AZIONI ENDOCRINE E EXTRA-ENDOCRINE DI GHRELIN E DEI GHS SINTETICI 62
Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors 61
Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans. 61
Growth hormone-independent cardiotropic activities of growth hormone-releasing peptides in normal subjects, in patients with growth hormone deficiency, and in patients with idiopathic or ischemic dilated cardiomyopathy. 61
Ormoni dell’ipofisi posteriore 60
Ghrelin and anterior pituitary function 60
Ghrelin and other gastrointestinal peptides involved in the control of food intake 60
Effects of glucose, free fatty acids or arginine load on the GH-releasing activity of ghrelin in humans. 59
Age-related variations in the neuroendocrine control, more than impaired receptor sensitivity, cause the reduction in the GH-releasing activity of GHRPs in human aging. 59
Known and unknown growth hormone secretagogue receptors and their ligands 59
CARDIOVASCULAR ACTIVITIES OF NATURAL AND SYNTHETIC GH SECRETAGOGUES 59
Myocardial Insulin-like Growth Factor-1 and Insulin-like Growth Factor Binding Protein-3 Gene Expression in Failing Hearts Harvested From Patients Undergoing Cardiac Transplantation 57
Ghrelin exerts an inhibitory modulation on LH pulsatility in humans. 57
EFFECTS OF CORTISTATIN-17 AND SOMATOSTATIN-14 ON ACTH AND CORTISOL HYPERSECRETION IN PATIENTS WITH CUSHING’S DISEASE 57
Endocrine activities of cortistatin-14 and its interaction with GHRH and ghrelin in humans 57
A New Clinical Model to Estimate the Pre-Test Probability of Cushing's Syndrome: The Cushing Score 57
The activity of GH/IGF-I axis in anorexia nervosa and in obesity: a comparison with normal subjects and patients with hypopituitarism or critical illness. 56
Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity 56
Totale 13.162
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.496
article - articoli 0
book - libri 0
conference - conferenze 3.867
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.363
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.415 0 0 219 285 208 482 299 155 241 211 199 116
2020/20212.383 194 130 220 118 278 121 231 121 288 297 148 237
2021/20222.066 77 100 119 125 146 114 147 120 84 189 338 507
2022/20232.990 335 226 54 276 288 734 276 229 277 69 135 91
2023/20241.341 174 233 98 85 91 129 59 75 23 69 118 187
2024/2025391 72 319 0 0 0 0 0 0 0 0 0 0
Totale 17.546